Showing results (1641-1650 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|October 31, 2017
Comparison of 208-week sequential therapy with telbivudine and entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg-IFNα-2a therapy: An open-labelled, randomized, controlled, "real-life" trialX D Luo, X F Chen, Y Zhou, et al.Journal of Viral Hepatitis|November 2, 2017
LncRNA expression profiles in HBV-transformed human hepatocellular carcinoma cells treated with a novel inhibitor of human La proteinJ Pan, S Tong, J TangJournal of Viral Hepatitis|August 24, 2017
Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II-III)S D Shafran, D Shaw, M Charafeddine, et al.Journal of Viral Hepatitis|October 7, 2017
Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4G Camus, B Han, T Asselah, et al.Journal of Viral Hepatitis|September 2, 2014
BMI, male sex and IL28B genotype associated with persistently high hepatitis C virus RNA levels among chronically infected drug users up to 23 years following seroconversionB P X Grady, M Prins, S Rebers, et al.Journal of Viral Hepatitis|October 30, 2015
Strategies to manage hepatitis C virus infection disease burden - volume 3F Z Alfaleh, N Nugrahini, M Matičič, et al.Journal of Viral Hepatitis|June 10, 2016
Insulin resistance increases loss of antibody to hepatitis B surface antigen in nondiabetic healthy adultsE-J Joo, J-S Yeom, M-J Kwon, et al.Journal of Viral Hepatitis|September 10, 2014
Elevated interferon-stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virusM W Robinson, R Swann, A Sigruener, et al.Journal of Viral Hepatitis|August 19, 2014
APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS)E Teshale, M Lu, L B Rupp, et al.Journal of Viral Hepatitis|August 19, 2014
Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infectionJ-Y Wang, R-C Mao, Y-M Zhang, et al.Pageof 362